Effects of 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(14)-β-D-canaropyranosyl]-17β-marsdenin on selected indices of cardiovascular diseases in mouse

Simple item page
dc.contributor.authorAdebayo, J. O.
dc.contributor.authorOrire, A. B.
dc.contributor.authorGyebi, G.A.
dc.contributor.authorOlorundare, O. E.
dc.contributor.authorBabatunde, A. S.
dc.date.accessioned2022-11-08T08:10:32Z
dc.date.available2022-11-08T08:10:32Z
dc.date.issued2022-02
dc.description.abstractSome anticancer pregnane glycosides, e.g., 3-O-[6-deoxy-3-O-methyl-β-d-allopyranosyl-(1 → 4)-β-d-canaropyranosyl]-17β- marsdenin (3DMACM), have been isolated from Gongronema latifolium leaves which have not been evaluated for their effects on the cardiovascular system. Thus, this study was carried out to evaluate the effects of 3DMACM on selected indices of cardiovascular diseases in albino mice. Forty mice were randomly divided into four groups (ten mice each). Group A mice were orally administered 5% DMSO while mice in groups B, C, and D were orally administered 0.25, 0.5, and 1 mg/ kg body weight of the compound for 14 days, after which various indices of cardiovascular diseases were determined. The results revealed that the total cholesterol, triacylglycerol, very low density lipoprotein-, and high-density lipoprotein-cholesterol concentrations in the plasma and heart Na+- K+-ATPase activity were significantly reduced (p < 0.05) at the doses of 0.25 and 1 mg/kg body weight of the compound compared to controls. Also, atherogenic index, plasma LDH activity, and heart Mg2+- ATPase activity of the mice were significantly (p < 0.05) reduced at all doses of the compound compared to controls. Heart and plasma creatine kinase activities and heart Ca2+- Mg2+-ATPase activity of mice were significantly (p < 0.05) reduced at doses higher than 0.25 mg/kg body weight of the compound compared to controls. AST activities in the heart and plasma of mice were significantly increased (p < 0.05) at doses of 0.25 and 1 mg/kg body weight compared to controls. The results suggest that 3DMACM may not predispose subjects to atherosclerosis but may adversely affect cardiac muscle contraction/relaxation, especially at higher doses.en_US
dc.identifier.citationAdebayo, J.O., Orire, A.B., Gyebi, G.A., Olorundare, O. E., Babatunde, A. S.(2022). Effects of 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(1 4)-β-D-canaropyranosyl]-17β-marsdenin on selected indices of cardiovascular diseases in mouse. Comparative Clinical Pathology, 31:155–168.en_US
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/20.500.12484/7822
dc.language.isoenen_US
dc.publisherSpringer Natureen_US
dc.subjectPregnane glycoside · Cardiovascular system · Toxicity · Plant · Muscle contractilityen_US
dc.titleEffects of 3-O-[6-deoxy-3-O-methyl-β-D-allopyranosyl-(14)-β-D-canaropyranosyl]-17β-marsdenin on selected indices of cardiovascular diseases in mouseen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Adebayo2022_Article_EffectsOf3-O-[6-deoxy-3-O-meth.pdf
Size:
5.55 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections